Knight GM - Search Results

1

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.

Achar J, Seddon JA, Knight GM, Dodd PJ, Esmail H, Hughes J, McQuaid CF. Achar J, et al. Among authors: knight gm. Eur Respir J. 2023 Nov 29;62(5):2300969. doi: 10.1183/13993003.00969-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37945035 No abstract available.

2

Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.

Dodd PJ, Knight GM, Lawn SD, Corbett EL, White RG. Dodd PJ, et al. Among authors: knight gm. PLoS One. 2013 Sep 17;8(9):e75466. doi: 10.1371/journal.pone.0075466. eCollection 2013. PLoS One. 2013. PMID: 24069418 Free PMC article.

3

Tuberculosis prevention in South Africa.

Knight GM, Dodd PJ, Grant AD, Fielding KL, Churchyard GJ, White RG. Knight GM, et al. PLoS One. 2015 Apr 7;10(4):e0122514. doi: 10.1371/journal.pone.0122514. eCollection 2015. PLoS One. 2015. PMID: 25849558 Free PMC article.

4

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.

Knight GM, Gomez GB, Dodd PJ, Dowdy D, Zwerling A, Wells WA, Cobelens F, Vassall A, White RG. Knight GM, et al. PLoS One. 2015 Dec 30;10(12):e0145796. doi: 10.1371/journal.pone.0145796. eCollection 2015. PLoS One. 2015. PMID: 26717007 Free PMC article.

5

Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.

Knight GM, McQuaid CF, Dodd PJ, Houben RMGJ. Knight GM, et al. Lancet Infect Dis. 2019 Aug;19(8):903-912. doi: 10.1016/S1473-3099(19)30307-X. Epub 2019 Jul 4. Lancet Infect Dis. 2019. PMID: 31281059 Free PMC article.

6

The risk of multidrug- or rifampicin-resistance in males versus females with tuberculosis.

McQuaid CF, Horton KC, Dean AS, Knight GM, White RG. McQuaid CF, et al. Among authors: knight gm. Eur Respir J. 2020 Sep 17;56(3):2000626. doi: 10.1183/13993003.00626-2020. Print 2020 Sep. Eur Respir J. 2020. PMID: 32430421 Free article.

7

Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults.

McQuaid CF, Cohen T, Dean AS, Houben RMGJ, Knight GM, Zignol M, White RG. McQuaid CF, et al. Among authors: knight gm. Eur Respir J. 2021 Feb 4;57(2):2002504. doi: 10.1183/13993003.02504-2020. Print 2021 Feb. Eur Respir J. 2021. PMID: 32855219 Free article.

8

Antimicrobial resistance and COVID-19: Intersections and implications.

Knight GM, Glover RE, McQuaid CF, Olaru ID, Gallandat K, Leclerc QJ, Fuller NM, Willcocks SJ, Hasan R, van Kleef E, Chandler CI. Knight GM, et al. Elife. 2021 Feb 16;10:e64139. doi: 10.7554/eLife.64139. Elife. 2021. PMID: 33588991 Free PMC article.

9

Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis.

Menzies NA, Allwood BW, Dean AS, Dodd PJ, Houben RMGJ, James LP, Knight GM, Meghji J, Nguyen LN, Rachow A, Schumacher SG, Mirzayev F, Cohen T. Menzies NA, et al. Among authors: knight gm. Nat Commun. 2023 Oct 4;14(1):6182. doi: 10.1038/s41467-023-41937-9. Nat Commun. 2023. PMID: 37794037 Free PMC article.

10

Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis.

Shrestha S, Knight GM, Fofana M, Cohen T, White RG, Cobelens F, Dowdy DW. Shrestha S, et al. Among authors: knight gm. Open Forum Infect Dis. 2014 Aug 30;1(2):ofu073. doi: 10.1093/ofid/ofu073. eCollection 2014 Sep. Open Forum Infect Dis. 2014. PMID: 25734143 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters